Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

SIEMENS HEALTHINEERS AG

(SHL)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Siemens Healthineers : Dr. Marion Helmes appointed independent Chairwoman of the Audit Committee of Siemens Healthineers AG

09/29/2021 | 07:32am EST

Press

Erlangen, September 27, 2021

Dr. Marion Helmes appointed independent Chairwoman of the Audit Committee of Siemens Healthineers AG

At its meeting today, the Supervisory Board of Siemens Healthineers AG

appointed Dr. Marion Helmes as Chairwoman of the Audit Committee. On September 28, 2021, she will take over the Chair from Dr. Andreas C. Hoffmann who has held this position since 2020. Marion Helmes has been an independent member of the Supervisory Board and its Audit Committee since the company's IPO in 2018.

"Thanks to her activities as a member and chair of the audit committees of several global corporations, Marion Helmes has extensive expertise in accounting, auditing and internal control procedures, and is therefore ideally suited to the new task," said Prof. Dr. Ralf P. Thomas, Chairman of the Supervisory Board of Siemens Healthineers AG.

In addition to her mandate at Siemens Healthineers, Ms. Helmes is, among other things, Vice Chairwoman of the Supervisory Board and a Member of the Audit Committee of ProSiebenSat.1 Media SE. Marion Helmes was CFO of Celesio AG from 2012 to 2014, as well as Speaker of the Management Board from 2013 to 2014. Prior to that, she held, inter alia, various management positions at ThyssenKrupp, including CFO of ThyssenKrupp Elevator.

In addition to Marion Helmes and Andreas C. Hoffmann, the Audit Committee of Siemens Healthineers AG also includes Ralf P. Thomas, Chairman of the Supervisory Board. The change at the head of the Committee takes place against the background of the DAX membership of Siemens Healthineers AG, and the corresponding need for an independent Chair of the Audit Committee. The tasks of the Audit Committee include overseeing the accounting process, and the audit of the financial statements, in particular the selection, independence and qualification of the auditor, assessing the quality of the audit and the performance of the auditor.

Siemens Healthineers AG

Henkestr. 127

Communications

91052 Erlangen, Germany

Dr. Matthias Kraemer

Page 1/2

Press release

Siemens Healthineers

You can find this press release and further information at https://www.siemens-healthineers.com/press/releases/audit-committee.

Contact for journalists

Matthias Kraemer

Phone: +49 9131 84-3383; E-mail: Matthias.Kraemer@siemens-healthineers.com

Follow the Press team on Twitter: https://twitter.com/siemenshealthpr

Siemens Healthineers AG (listed in Frankfurt a.M. under SHL) is committed to shaping the healthcare system of the future. As one of the leading medical engineering companies headquartered in Erlangen, Germany, it supports healthcare providers worldwide through its regional companies to achieve higher goals on their journey toward expanding precision medicine, transforming healthcare, improving the patients' experience, and digitalizing the healthcare system. Siemens Healthineers is continuously developing its portfolio of products and services, with AI-based applications and digital offerings that will play an increasingly important role in the next generation of medical technology. These new applications will further strengthen the company in in-vitro diagnostics, image-based therapy, in-vivo diagnostics and innovative cancer treatment. Siemens Healthineers also offers a range of services and solutions to improve the ability of healthcare providers to provide high-quality and efficient care to patients. In fiscal year 2020, which ended on September 30, 2020, Siemens Healthineers generated sales of €14.5 billion and an adjusted EBIT of €2.2 billion. Following the acquisition of Varian Medical Systems, Inc., the company has approximately 66,000 employees worldwide. Further information is available at www.siemens-healthineers.com.

Page 2/2

Disclaimer

Siemens Healthineers AG published this content on 27 September 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 29 September 2021 11:31:03 UTC.


ę Publicnow 2021
All news about SIEMENS HEALTHINEERS AG
09:04aBiotechnology firm Freenome raises $300 million in fresh funding
RE
12/06SIEMENS HEALTHINEERS AG : Release of a capital market information
EQ
12/06Siemens AGMunich; Supervisory Board renews the term of office of Ralf Thomas, Managing ..
AQ
12/03Siemens AG - Supervisory Board renews the term of office of Ralf Thomas, Managing Board..
AQ
12/02Siemens Renews CFO's Term Of Office
MT
12/02Siemens Renews Term for CFO Ralf Thomas
DJ
12/02Atos and Siemens to support Morocco in the smart management of its power grid
AQ
12/01Freenome Partners with Siemens Healthineers for Breast Cancer Research
CI
11/29SIEMENS HEALTHINEERS AG : Release of a capital market information
EQ
11/26Siemens AG - Halfway point of 2023 research period for Aspern Smart City Research
AQ
More news
Analyst Recommendations on SIEMENS HEALTHINEERS AG
More recommendations
Financials
Sales 2022 19 879 M 22 361 M 22 361 M
Net income 2022 1 938 M 2 180 M 2 180 M
Net Debt 2022 11 991 M 13 488 M 13 488 M
P/E ratio 2022 36,5x
Yield 2022 1,48%
Capitalization 71 523 M 80 662 M 80 451 M
EV / Sales 2022 4,20x
EV / Sales 2023 3,86x
Nbr of Employees 66 000
Free-Float 24,2%
Chart SIEMENS HEALTHINEERS AG
Duration : Period :
Siemens Healthineers AG Technical Analysis Chart | SHL | DE000SHL1006 | MarketScreener
Technical analysis trends SIEMENS HEALTHINEERS AG
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 19
Last Close Price 63,76 €
Average target price 67,97 €
Spread / Average Target 6,61%
EPS Revisions
Managers and Directors
Bernhard Montag Chief Executive Officer
Jochen Schmitz Chief Financial Officer
Ralf Peter Thomas Chairman-Supervisory Board
Thorsten Opderbeck Head-Technology, Trade & Regional Media
A. Gregory Sorensen Member-Supervisory Board
Sector and Competitors